Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published July 2025 · Last reviewed May 2026
The Med Device Cyber Podcast · July 1, 2025 In this episode of The Med Device Cyber Podcast, Mark Swanson and Steve Gumpertz from QRX Partners guide listeners through the complex world of medical device regulatory approval, emphasizing the critical role of robust quality systems and early expert engagement. They offer invaluable insights for product security teams, regulatory leads, and engineers, particularly those in early-stage MedTech startups. The discussion highlights common pitfalls, such as misinterpreting FDA guidance and underestimating the time and financial investment required for compliance. Swanson and Gumpertz delve into the nuances of device classification, the intricacies of 510(k) and De Novo pathways, and the challenges of defining “cyber device” in the context of evolving software and connectivity standards. The conversation also explores the rapidly changing landscape of AI and machine learning in medical devices, contrasting the regulatory approaches of the US and Europe and underscoring the importance of understanding standards like ISO 13485 and IEC 62304. Listeners will learn why proactive regulatory strategy and expert consultation are essential to navigate the intricate journey from concept to market.
Key Takeaways
- Early engagement with regulatory experts is crucial for medical device startups to navigate complex pathways and avoid costly delays.
- Misinterpreting FDA guidance, particularly regarding device classification and the definition of a “cyber device,” is a common pitfall that can lead to significant setbacks.
- Even devices with inaccessible firmware or basic display screens are often considered “cyber devices” by the FDA, necessitating comprehensive software and cybersecurity documentation and testing.
- The rapidly evolving nature of AI and machine learning in medical devices presents unique regulatory challenges, with a key distinction made between AI as a development tool and AI implemented within a device that learns in the field.
- Proactive quality system development and adherence to applicable standards such as ISO 13485 and the latest amendments to IEC 62304 are fundamental for successful regulatory submission.
- Preventive action and early consultation are far more cost-effective than corrective action and arguing with regulatory bodies like the FDA.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.